TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -15.8% | 28,500 | 0.0% | 0.07% | -17.5% |
| Q2 2022 | $57,000 | -24.0% | 28,500 | 0.0% | 0.08% | +1.3% |
| Q1 2022 | $75,000 | -5.1% | 28,500 | 0.0% | 0.08% | +38.6% |
| Q4 2021 | $79,000 | -28.2% | 28,500 | 0.0% | 0.06% | 0.0% |
| Q3 2021 | $110,000 | -40.5% | 28,500 | 0.0% | 0.06% | -40.0% |
| Q2 2021 | $185,000 | – | 28,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,190,000 | $6,997,000 | 2.89% |
| Ikarian Capital, LLC | 2,765,530 | $4,618,000 | 0.92% |
| Telemetry Investments, L.L.C. | 97,000 | $162,000 | 0.21% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $48,000 | 0.07% |
| JOHNSON & JOHNSON | 84,003 | $140,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $579,000 | 0.03% |
| X-Square Capital, LLC | 17,973 | $30,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $432,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $760,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $79,000 | 0.00% |